Muren, O., Akbarian, E., Salemyr, M., Bodén, H., Eisler, T., Stark, A., & Sköldenberg, O. (2015). No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty: A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial. Acta Orthop.
Chicago Style CitationMuren, Olle, Ehsan Akbarian, Mats Salemyr, Henrik Bodén, Thomas Eisler, André Stark, and Olof Sköldenberg. "No Effect of Risedronate On Femoral Periprosthetic Bone Loss Following Total Hip Arthroplasty: A 4-year Follow-up of 61 Patients in a Double-blind, Randomized Placebo-controlled Trial." Acta Orthop 2015.
MLA CitationMuren, Olle, et al. "No Effect of Risedronate On Femoral Periprosthetic Bone Loss Following Total Hip Arthroplasty: A 4-year Follow-up of 61 Patients in a Double-blind, Randomized Placebo-controlled Trial." Acta Orthop 2015.